Skip to main content
. Author manuscript; available in PMC: 2013 Jun 1.
Published in final edited form as: Bone. 2012 Mar 19;50(6):1214–1222. doi: 10.1016/j.bone.2012.03.011

Table 1. Body Weight Correlations.

Standard Recovery
Water MP-Low MP-High Water MP-Low MP-High
R p-value R p-value R p-value R p-value R p-value R p-value
Femora AP Diameter 0.534 0.074 0.624 <0.050 0.368 0.240 −0.129 0.690 0.267 0.401 0.422 0.171
ML Diameter 0.333 0.290 0.535 0.073 0.198 0.537 0.102 0.754 0.854 <0.001 0.728 <0.010
Length 0.834 <0.001 0.491 0.105 0.596 <0.050 0.056 0.864 0.886 <0.001 0.068 <0.050
BMD 0.087 0.789 0.578 <0.050 0.490 0.106 −0.170 0.597 0.680 <0.050 0.779 <0.010
BMC 0.678 <0.050 0.807 0.001 0.648 <0.050 −0.172 0.592 0.892 <0.001 0.816 0.001
Area 0.926 <0.001 0.700 0.010 0.752 <0.010 −0.147 0.649 0.931 <0.001 0.743 <0.010
Ultimate Force 0.132 0.682 0.674 <0.050 0.443 0.150 0.175 0.585 0.182 0.592 0.230 0.497
Stiffness 0.476 0.118 0.591 <0.050 0.367 0.241 −0.072 0.823 0.138 0.668 0.164 0.610
Energy to Failure 0.462 0.131 0.248 0.437 0.195 0.543 0.200 0.534 0.467 0.147 0.244 0.470
Tibiae BMD 0.069 0.832 0.666 <0.050 0.574 0.050 −0.290 0.361 0.585 <0.050 0.698 0.010
BMC 0.641 <0.050 0.809 0.001 0.620 <0.050 −0.252 0.429 0.805 <0.010 0.783 <0.010
Area 0.830 <0.001 0.681 <0.050 0.652 <0.050 −0.204 0.525 0.848 <0.001 0.766 <0.010
Serum CTX 0.743 0.257 0.137 0.863 −0.760 0.240 0.077 0.923 −0.006 0.994 0.687 0.313
ALP −0.266 0.457 −0.270 0.396 −0.554 0.062 0.036 0.911 0.325 0.302 0.041 0.899
Testosterone 0.389 0.267 0.212 0.532 0.067 0.864 0.386 0.27 0.312 0.324 0.659 <0.050

This table presents the results of linear regression and correlation analyses performed between body weight at sacrifice and the caliper, DXA, biomechanics, and biomarker results from the three treatment groups (Water, MP-Low, and MP-High) analyzed immediately after 13 weeks of treatment (Standard) and following 5 weeks of untreated recovery (Recovery). Sample identities are given in the first column, followed by the outcomes, R-values, and p-values, for each treatment group and dosing protocol. Significant correlations are marked in bold.